In Search of the Perfect Comorbidity Measure for Use With Administrative Claims Data
Does It Exist
Dados Bibliográficos
| ID | 9102519 |
|---|---|
| Autores | Laura-Mae Baldwin, Laura–Mae Baldwin (University of Washington, autor correspondente), Carrie N Klabunde (National Cancer Institute), Pam Green (University of Washington, autor correspondente), William Barlow (University of Washington), George Wright (0000-0003-0867-1266), George E Wright (0000-0002-5812-6533, University of Washington, autor correspondente) |
| Ano | 2006 |
| Volume | 44 |
| Fascículo | 8 |
| Páginas | 745-753 |
| Data de publicação | 2006-08-01 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | Medical Care (JOURNAL) |
| Identificadores do periódico | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editora | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000223475.70440.07 |
| PMID | 16862036 |
| PMCID | PMC3124350 |
| OpenAlex | W2085509059 |
| Idioma | EN |
| Citações recebidas | 13 |
| Referências citadas | 23 |
BACKGROUND: Numerous measures of comorbidity have been developed for health services research with administrative claims. OBJECTIVE: We sought to compare the performance of 4 claims-based comorbidity measures. RESEARCH DESIGN AND SUBJECTS: We undertook a retrospective cohort study of 5777 Medicare beneficiaries ages 66 and older with stage III colon cancer reported to the Surveillance, Epidemiology, and End Results Program between January 1, 1992 and December 31, 1996. MEASURES: Comorbidity measures included Elixhauser's set of 30 condition indicators, Klabunde's outpatient and inpatient indices weighted for colorectal cancer patients, Diagnostic Cost Groups, and the Adjusted Clinical Group (ACG) System. Outcomes included receipt of adjuvant chemotherapy and 2 year noncancer mortality. RESULTS: For all measures, greater comorbidity significantly predicted lower receipt of chemotherapy and higher noncancer death. Nested logistic regression modeling suggests that using more claims sources to measure comorbidity generally improves the prediction of chemotherapy receipt and noncancer death, but depends on the measure type and outcome studied. All 4 comorbidity measures significantly improved the fit of baseline regression models for both chemotherapy receipt (baseline c-statistic 0.776; ranging from 0.779 after adding ACGs and Klabunde to 0.789 after Elixhauser) and noncancer death (baseline c-statistic 0.687; ranging from 0.717 after adding ACGs to 0.744 after Elixhauser). CONCLUSIONS: Although some comorbidity measures demonstrate minor advantages over others, each is fairly robust in predicting both chemotherapy receipt and noncancer death. Investigators should choose among these measures based on their availability, comfort with the methodology, and outcomes of interest
Comorbidity · Logistic regression · Receipt · Retrospective cohort study · Chronic Disease Management Strategies · Emergency Medicine · Epidemiology · Global Cancer Incidence and Screening · Internal Medicine · Medicine · Primary Care and Health Outcomes
Prostate Cancer Treatment and Survival
Validation of Disability Status, a Claims-based Measure of Functional Status for Cancer Treatment and Outcomes Studies
Health Information Technology and its Effects on Hospital Costs, Outcomes, and Patient Safety
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Regional and Temporal Variations in Comorbidity Among US Dialysis Patients
Adolescent outcomes and opportunities in a Canadian province
The association of socioeconomic disadvantage with postoperative complications after major elective cardiovascular surgery
Should We Add Clinical Variables to Administrative Data
The Contribution of Longitudinal Comorbidity Measurements to Survival Analysis
Response to Letter From Harvey J. Sugerman, MD
Incremental Value of Using Medicaid Claim Files to Study Comorbid Conditions and Treatments in Dually Eligible Beneficiaries
Incorporating New Research Into Medicare Risk Adjustment
Inadequate Access to Surgeons
The Jackknife, the Bootstrap and Other Resampling Plans
Development of a comorbidity index using physician claims data
Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
Assessing Comorbidity Using Claims Data
Comorbidity Measures for Use with Administrative Data
Can Pharmacy Data Improve Prediction of Hospital Outcomes
Comparison of Comorbidity Indices for Patients With Head and Neck Cancer
A Comprehensive Prognostic Index to Predict Survival Based on Multiple Comorbidities
Comparison of the Elixhauser and Charlson/Deyo Methods of Comorbidity Measurement in Administrative Data
Patient Demographic and Socioeconomic Characteristics in the Seer-Medicare Database
Comparison of the Performance of Two Comorbidity Measures, With and Without Information From Prior Hospitalizations
| Obras citantes distintas | 13 |
|---|---|
| Citações por ano | 0,65 |
| Intervalo de citações | 2006 - 2018 (13) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 11 |